Forbes | Safeguarding And Streamlining Pharma Supply Chain: Time For Mandating Certified Drugs

Forbes released an article titled, "Safeguarding And Streamlining Pharma Supply Chain: Time For Mandating Certified Drugs," which highlights our discovery of another cancer-causing chemical solvent, dimethylformamide, in widely prescribed blood-pressure pills. This solvent was discovered in the drug Valsartan made by several companies, including in those made by Swiss pharmaceutical giant Novartis AG.

Real the full article via Forbes here.

Forbes | Safeguarding And Streamlining Pharma Supply Chain: Time For Mandating Certified Drugs

April 20, 2022

Forbes released an article titled, "Safeguarding And Streamlining Pharma Supply Chain: Time For Mandating Certified Drugs," which highlights our discovery of another cancer-causing chemical solvent, dimethylformamide, in widely prescribed blood-pressure pills. This solvent was discovered in the drug Valsartan made by several companies, including in those made by Swiss pharmaceutical giant Novartis AG.

Real the full article via Forbes here.

Forbes | Safeguarding And Streamlining Pharma Supply Chain: Time For Mandating Certified Drugs

Forbes released an article titled, "Safeguarding And Streamlining Pharma Supply Chain: Time For Mandating Certified Drugs," which highlights our discovery of another cancer-causing chemical solvent, dimethylformamide, in widely prescribed blood-pressure pills. This solvent was discovered in the drug Valsartan made by several companies, including in those made by Swiss pharmaceutical giant Novartis AG.

Real the full article via Forbes here.

Forbes released an article titled, "Safeguarding And Streamlining Pharma Supply Chain: Time For Mandating Certified Drugs," which highlights our discovery of another cancer-causing chemical solvent, dimethylformamide, in widely prescribed blood-pressure pills. This solvent was discovered in the drug Valsartan made by several companies, including in those made by Swiss pharmaceutical giant Novartis AG.

Real the full article via Forbes here.

SIGN UP FOR THE VALISURE NEWSLETTER 

Sign up to stay updated with Valisure announcements, relevant industry news, company updates, and more. 

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.